by Kirsten Chalmers | Aug 17, 2022 | Health technology assessment, Healthcare, Market access, NICE
Designed to help healthcare stakeholders identify more urgent health needs, the concept of “unmet medical need” is being increasingly applied formally and informally to set priorities during the development, assessment, and reimbursement of new drugs and medical...
by Kirsten Chalmers | Nov 24, 2021 | Budget impact, Market access
What is a budget impact analysis? Pressure on healthcare insurers to fund the best available care while keeping within budgetary constraints has made budget impact analysis (BIA) an increasingly important part of any application for getting new drugs or medical...
